JP2022543765A5 - - Google Patents
Info
- Publication number
- JP2022543765A5 JP2022543765A5 JP2022506056A JP2022506056A JP2022543765A5 JP 2022543765 A5 JP2022543765 A5 JP 2022543765A5 JP 2022506056 A JP2022506056 A JP 2022506056A JP 2022506056 A JP2022506056 A JP 2022506056A JP 2022543765 A5 JP2022543765 A5 JP 2022543765A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- conjugate
- tumor
- antibody
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962880514P | 2019-07-30 | 2019-07-30 | |
| US62/880,514 | 2019-07-30 | ||
| US201962896453P | 2019-09-05 | 2019-09-05 | |
| US62/896,453 | 2019-09-05 | ||
| US201962931405P | 2019-11-06 | 2019-11-06 | |
| US62/931,405 | 2019-11-06 | ||
| PCT/US2020/043999 WO2021021882A1 (en) | 2019-07-30 | 2020-07-29 | Near-infrared (nir) photoimmunotherapy (pit) for the treatment of cancers using anti-cd25 antybody-phthalocyanine dye conjugate and anti-pd1 antibody |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022543765A JP2022543765A (ja) | 2022-10-14 |
| JP2022543765A5 true JP2022543765A5 (enExample) | 2023-08-04 |
| JP7627259B2 JP7627259B2 (ja) | 2025-02-05 |
Family
ID=72047165
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022506056A Active JP7627259B2 (ja) | 2019-07-30 | 2020-07-29 | 抗ｃｄ２５抗体－フタロシアニン色素コンジュゲートおよび抗ｐｄ１抗体を使用したがんの処置のための近赤外（ｎｉｒ）光免疫療法（ｐｉｔ） |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20220313822A1 (enExample) |
| EP (1) | EP4004048A1 (enExample) |
| JP (1) | JP7627259B2 (enExample) |
| CN (1) | CN114423453A (enExample) |
| TW (1) | TW202118518A (enExample) |
| WO (1) | WO2021021882A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11154620B2 (en) | 2015-08-18 | 2021-10-26 | Rakuten Medical, Inc. | Compositions, combinations and related methods for photoimmunotherapy |
| ES2889904T3 (es) | 2015-08-18 | 2022-01-14 | Rakuten Medical Inc | Conjugados de colorante de ftalocianina y su almacenamiento |
| CN115052631A (zh) * | 2019-12-06 | 2022-09-13 | 乐天医药生技股份有限公司 | 用于增强免疫及肿瘤治疗的方法 |
| JP2024505556A (ja) * | 2021-02-02 | 2024-02-06 | ラクテン・メディカル，インコーポレイテッド | がん、腫瘍および腫瘍細胞の局所および全身処置のための方法 |
| EP4547274A1 (en) * | 2022-06-30 | 2025-05-07 | The United States of America, as represented by the Secretary, Department of Health and Human Services | Cd25-specific antibodies and uses thereof |
| WO2024165454A1 (en) * | 2023-02-06 | 2024-08-15 | F. Hoffmann-La Roche Ag | Combination therapy and uses thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2841120C (en) * | 2011-07-11 | 2020-10-27 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Antibody-ir700 conjugates for photodynamic therapy |
| US10830678B2 (en) * | 2014-08-08 | 2020-11-10 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Serv | Photo-controlled removal of targets in vitro and in vivo |
| CN121270700A (zh) * | 2015-08-07 | 2026-01-06 | 美国政府(由卫生和人类服务部的部长所代表) | 用于治疗癌症的针对抑制细胞的近红外光免疫疗法(nir-pit) |
| US11154620B2 (en) * | 2015-08-18 | 2021-10-26 | Rakuten Medical, Inc. | Compositions, combinations and related methods for photoimmunotherapy |
| CA3070469C (en) | 2016-10-25 | 2022-06-21 | Rakuten Medical, Inc. | Light diffusing devices for use in photoimmunotherapy |
| US10416366B2 (en) | 2016-10-25 | 2019-09-17 | Rakuten Medical, Inc. | Light diffusing devices for use in photoimmunotherapy |
| WO2019083971A1 (en) * | 2017-10-23 | 2019-05-02 | Children's Medical Center Corporation | METHODS OF TREATING CANCER USING LSD1 INHIBITORS IN COMBINATION WITH IMMUNOTHERAPY |
| JP2021521135A (ja) * | 2018-04-10 | 2021-08-26 | ザ ユナイテッド ステイツ オブ アメリカ， アズ リプレゼンテッド バイ ザ セクレタリー， デパートメント オブ ヘルス アンド ヒューマン サービシーズ | がん細胞を標的とする近赤外光線免疫療法および宿主免疫活性化の組合せ |
-
2020
- 2020-07-29 CN CN202080065407.6A patent/CN114423453A/zh active Pending
- 2020-07-29 JP JP2022506056A patent/JP7627259B2/ja active Active
- 2020-07-29 US US17/630,854 patent/US20220313822A1/en active Pending
- 2020-07-29 TW TW109125563A patent/TW202118518A/zh unknown
- 2020-07-29 WO PCT/US2020/043999 patent/WO2021021882A1/en not_active Ceased
- 2020-07-29 EP EP20754590.6A patent/EP4004048A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022543765A5 (enExample) | ||
| Malik et al. | Futuristic approach to cancer treatment | |
| JP2014132009A5 (enExample) | ||
| JP5623016B2 (ja) | 癌治療法およびそれに用いる医薬組成物 | |
| JP2012500180A5 (enExample) | ||
| US20220313822A1 (en) | Near-infrared (nir) photoimmunotherapy (pit) for the treatment of cancers using anti-cd25 antibody-phthalocyanine dye conjugate and anti-pd1 antibody | |
| WO2021182573A1 (ja) | 癌の治療及び／又は予防のための医薬品 | |
| Hallqvist et al. | Dose escalation to 84 Gy with concurrent chemotherapy in stage III NSCLC appears excessively toxic: Results from a prematurely terminated randomized phase II trial | |
| JP2021505571A (ja) | 末梢ｔ細胞リンパ腫および皮膚ｔ細胞リンパ腫を治療するための組成物および方法 | |
| EP4119557A1 (en) | Pharmaceutical combination comprising pyridino[1,2-a]pyrimidinone compound | |
| JP2023505222A5 (enExample) | ||
| JP2025163103A (ja) | 放射線および／または抗がん治療補助療法としてアデノシン二リン酸リボースの活用 | |
| Larkin | Investigational RSV vaccine given during pregnancy protects newborns | |
| Lan et al. | Beyond boundaries: unraveling innovative approaches to combat bone-metastatic cancers | |
| Serre et al. | Brachytherapy: perspectives for combined treatments with immunotherapy | |
| Chambial et al. | Conventional methods of cancer therapy | |
| WO2021182571A1 (ja) | 癌の治療及び／又は予防のための医薬品 | |
| Cerbon et al. | Abscopal effect observed in visceral and osseous metastases after liver SBRT in combination with nivolumab and relatlimab for sinonasal mucosal melanoma—a case report | |
| RU2123827C1 (ru) | Способ лечения злокачественных опухолей | |
| Chen et al. | Escalated hyperfractionated accelerated radiation therapy for locally advanced non-small cell lung cancer: A clinical phase II trial | |
| South-East European Oncology Group (SEEOG) et al. | Phase II study of 4′-epi-doxorubicin in patients with untreated, extensive small cell lung cancer | |
| CN111773388B (zh) | A-失碳-5α雄甾烷化合物类药物与抗癌药物的联合应用 | |
| US20190015393A1 (en) | The use of a temporary inhibitor of p53 for preventing or reducing cancer relapse | |
| Peng et al. | Tumor therapeutic modes | |
| JP2019513826A (ja) | 放射線療法の改善 |